Yamo Deniz, MD, FAAAAI

VP Global Medical Affairs, Head, Immunology Global Medical Franchise
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA

Poster(s):

• (410) Baseline Characteristics of Patients on Medium-Versus High-Dose Inhaled Corticosteroids in Patients Initiating Dupilumab in a Real-World Clinical Setting: The RAPID Registry
  Wednesday, October 29, 2025